Autologous serum eye drops with added hyaluronic acid: a noncontrastive analysis of the effect on keratconjunctival disorder

Autologous serum eye drops with added hyaluronic acid: a noncontrastive analysis of the effect on keratconjunctival disorder - A noncontrastive analysis of autologous serum eye drops with added hyaluronic acid

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002699

Enrollment

100

Registered

2009-11-15

Start date

2008-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

keratoconjunctival dysfunction,severe dry eye,late-onset bleb leak after trabeculectomy

Interventions

autologous serum eye drops added hyaluronic acid(autologous serum50%,hyaleinmini0.3,33%,cravit16.7%)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: paient with severe keratoconjunctival dysfunction

Exclusion criteria

Exclusion criteria: patient who has allergy to hyaleinmini0.3 and cravit

Design outcomes

Primary

Measure	Time frame
evaluation of keratconjunctival disorder with slit lamp, visual acuity	—

Countries

Japan

Contacts

Public ContactHideto Sagara

Marui Eye Clinic Director

hide1234@ruby.ocn.ne.jp0244-25-7488

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026